Evidence map›Paper›PMID 33799414›Full record

ReviewMicroorganisms2021

Phage Therapy for Mycobacterium Abscessus and Strategies to Improve Outcomes.

Abdolrazagh Hashemi Shahraki, Mehdi Mirsaeidi

Open access · goldAbstract readReview
In one paragraph

Review in Microorganisms, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Mycobacteriophages and Their Applications.Antibiotics (Basel, Switzerland) · 2024
    Review
  7. Phage therapy: breathing new tactics into lower respiratory tract infection treatments.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  8. Review
  9. Atypical Mycobacteriosis Due toPathogens (Basel, Switzerland) · 2022
    Article
  10. Alternatives to Antibiotics againstAntibiotics (Basel, Switzerland) · 2022
    Review
  11. Microorganisms · 2022
    Review
  12. Insertion Mutation ofInfection and drug resistance · 2022
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Abdolrazagh Hashemi ShahrakiDivision of Pulmonary and Critical Care, Sleep and Allergy, Miller School of Medicine, University of Miami, Miami, FL 33101, USA.ORCID 0000-0003-1852-194X
Mehdi MirsaeidiDivision of Pulmonary and Critical Care, Sleep and Allergy, Miller School of Medicine, University of Miami, Miami, FL 33101, USA.ORCID 0000-0001-5298-8442
University of Miami · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Members of

Indexed as

mycobacterialmycobacteriophagesMycobacterium abscessusphage therapy

Identifiers

PMID33799414
PMCPMC7999966
OpenAlexW3136602558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.